Bacteremia due to Staphylococcus cohnii ssp. urealyticus caused by infected pressure ulcer: Case report and review of the literature;Bacteremia por Staphylococcus cohnii ssp. urealyticus devida a úlcera de pressão infectada: Relato de caso e revisão da literatura

Sao Paulo Medical Journal

Volumn 131, Issue 1, 2013, Pages 59-61

  Soldera, Jonathan ^a   Nedel, Wagner Luis ^b   Cardoso, Paulo Ricardo Cerveira ^a   d'Azevedo, Pedro Alves ^c  

^a HOSPITAL NOSSA SENHORA DA CONCEIÇÃO   (Brazil)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^c UNIVERSIDADE FEDERAL DE CIÊNCIAS DA SAÚDE DE PORTO ALEGRE   (Brazil)

Author keywords

Bacteremia; Community acquired infections; Dementia; Pressure ulcer; Staphylococcal infections

Indexed keywords

C REACTIVE PROTEIN; CEFALOTIN; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; GENTAMICIN; MEROPENEM; OXACILLIN; PIPERACILLIN PLUS TAZOBACTAM; TETRACYCLINE; VANCOMYCIN; COAGULASE;

AGED; AGITATION; ARTICLE; BLOOD CULTURE; BONE BIOPSY; CASE REPORT; DECUBITUS; DISORIENTATION; DROWSINESS; FEVER; GRAM NEGATIVE BACTERIUM; HOSPITAL READMISSION; HUMAN; INFECTION; LEUKOCYTE COUNT; MALE; MULTIINFARCT DEMENTIA; NONHUMAN; PRESSURE ULCER INFECTION; STAPHYLOCOCCAL BACTEREMIA; STAPHYLOCOCCUS; STAPHYLOCOCCUS COHNII; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TACHYCARDIA; TACHYPNEA; BACTEREMIA; CLASSIFICATION; COMPLICATION; CROSS INFECTION; DIFFERENTIAL DIAGNOSIS; GROWTH, DEVELOPMENT AND AGING; MICROBIOLOGY; STAPHYLOCOCCUS INFECTION;

AGED; BACTEREMIA; COAGULASE; CROSS INFECTION; DIAGNOSIS, DIFFERENTIAL; HUMANS; MALE; PRESSURE ULCER; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS;

EID: 84875542949     PISSN: 15163180     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1516-31802013000100010     Document Type: Article

References (10)

1. Richards MJ, Edwards JR, Culver DH, Gaynes RP. Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System. Crit Care Med. 1999;27(5):887-92.
2. Wisplinghoff H, Bischoff T, Tallent SM, et al. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis. 2004;39(3):309-17.
3. Kirchhoff LV, Sheagren JN. Epidemiology and clinical significance of blood cultures positive for coagulase-negative staphylococcus. Infect Control. 1985;6(12):479-86.
4. Sader HS, Sampaio JL, Zoccoli C, Jones RN. Results of the 1997 SENTRY Antimicrobial Surveillance Program in Three Brazilian Medical Centers. Braz J Infect Dis. 1999;3(2):63-79.
5. Pfaller MA, Herwaldt LA. Laboratory, clinical, and epidemiological aspects of coagulase-negative staphylococci. Clin Microbiol Rev. 1988;1(3):281-99.
6. Drozenová J, Petrás P. [Characteristics of coagulase-negative staphylococci isolated from hemocultures]. Epidemiol Mikrobiol Imunol. 2000;49(2):51-8.
7. de Allori MC, Jure MA, Romero C, de Castillo ME. Antimicrobial resistance and production of biofilms in clinical isolates of coagulase-negative Staphylococcus strains. Biol Pharm Bull. 2006;29(8):1592-6.
8. Koksal F, Yasar H, Samasti M. Antibiotic resistance patterns of coagulase-negative staphylococcus strains isolated from blood cultures of septicemic patients in Turkey. Microbiol Res. 2009;164(4):404-10.
9. Del'Alamo L, Cereda RF, Tosin I, Miranda EA, Sader HS. Antimicrobial susceptibility of coagulase-negative staphylococci and characterization of isolates with reduced susceptibility to glycopeptides. Diagn Microbiol Infect Dis. 1999;34(3):185-91.
10. Petinaki E, Kanellopoulou M, Damani A, et al. Linezolid-resistant Staphylococcus cohnii, Greece. Emerg Infect Dis. 2009;15(1):116-8.